YW
YE WEIGUO disclosed sale in GYRE THERAPEUTICS Inc
YE WEIGUO, Chief Operating Officer, disclosed a sale transaction in GYRE THERAPEUTICS Inc (GYRE) on 2026-05-21.
Action
Sale
Capital
$78,843 reported value
Insider Form 4 Activity1 evidence source
Why it matters
Insider Form 4 disclosures can surface management and director trading activity. This card is generated from pre-ingested disclosure data, not from request-time scraping.